This is mostly mediated by hypoxia inducible factor-1- alpha (HIF-1α), which is over-expressed in HNSCC, and plays a central role in hypoxia-induced therapeutic resistance in HNSCC through its role in initiating angiogenesis and regulating cellular metabolism to overcome hypoxia [77]. The gene discussed is HIF1A; the disease is head and neck squamous cell carcinoma.